{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:30:11Z","timestamp":1780428611665,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-019-2030-y","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:02:53Z","timestamp":1556150573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac resynchronization therapy improves heart failure in one patient with acromegaly-induced cardiomyopathy: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Jun yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian xiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao jia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"2030_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1023\/A:1009965803750","volume":"2","author":"IM Holdaway","year":"1999","unstructured":"Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary. 1999;2:29\u201341.","journal-title":"Pituitary"},{"key":"2030_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1023\/A:1020750514954","volume":"4","author":"G Vitale","year":"2001","unstructured":"Vitale G, Pivonello R, Galderisi M, et al. Cardiovascular complications in acromegaly: methods of assessment. Pituitary. 2001;4:251\u20137.","journal-title":"Pituitary"},{"issue":"6","key":"2030_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1046\/j.1365-2265.2003.01780.x","volume":"59","author":"L Sacc\u00e0","year":"2003","unstructured":"Sacc\u00e0 L, Napoli R, Cittadini A. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol. 2003;59(6):660\u201371.","journal-title":"Clin Endocrinol"},{"issue":"4)","key":"2030_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1023\/B:PITU.0000023427.31609.a2","volume":"6","author":"MP Matta","year":"2003","unstructured":"Matta MP, Caron P. Acromegalic cardiomyopathy: a review of the literature. Pituitary. 2003;6(4)):203\u20137.","journal-title":"Pituitary."},{"key":"2030_CR5","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ijcard.2012.11.109","volume":"167","author":"S Mosca","year":"2013","unstructured":"Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, Parente A, Conte S, Rengo G, Leosco D, Trimarco B, Filardi PP. Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol. 2013;167:1712\u20138.","journal-title":"Int J Cardiol"},{"key":"2030_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2165\/00024677-200403050-00004","volume":"3","author":"G Vitale","year":"2004","unstructured":"Vitale G, Pivonello R, Lombardi G, Colao A. Cardiac abnormalities in acromegaly: pathophysiology and implications for management. Treat Endocrinol. 2004;3:309\u201318.","journal-title":"Treat Endocrinol"},{"key":"2030_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the Heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"10","key":"2030_CR8","first-page":"961","volume":"19","author":"N Nazari","year":"2014","unstructured":"Nazari N, Keykhavani A, Sayah S, Hekmat M, Golabchi A, Rad MA, Alizadeh A, Heidarali M. Role of electrophysiological study in patients with syncope and bundle branch block. J Res Med Sci. 2014;19(10):961\u20134.","journal-title":"J Res Med Sci"},{"key":"2030_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"M Brignole","year":"2013","unstructured":"Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European society of cardiology (ESC). Developed in collaboration with the European heart rhythm association (EHRA). Eur Heart J. 2013;34:2281\u2013329.","journal-title":"Eur Heart J"},{"key":"2030_CR10","first-page":"330","volume":"68","author":"RP Butt","year":"1995","unstructured":"Butt RP, Laurent GJ, Bishop JE. Collagen deposition and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol. 1995;68:330\u20135.","journal-title":"Eur J Cell Biol"},{"key":"2030_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/eje.0.1320195","volume":"132","author":"A Br\u00fcel","year":"1995","unstructured":"Br\u00fcel A, Oxlund H. Biosynthetic growth hormone increase the collagen deposition rate in rat aorta and heart. Eur J Endocrinol. 1995;132:195\u20139.","journal-title":"Eur J Endocrinol"},{"key":"2030_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.CIR.0000027563.44593.CC","volume":"106","author":"A Juul","year":"2002","unstructured":"Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002;106:939\u201344.","journal-title":"Circulation"},{"key":"2030_CR13","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1210\/jc.2004-2088","volume":"90","author":"SP Johnsen","year":"2005","unstructured":"Johnsen SP, Hundborg HH, S\u00f8rensen HT, Orskov H, Tj\u00f8nneland A, Overvad K, J\u00f8rgensen JO. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab. 2005;90:5937\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.7326\/0003-4819-139-8-200310210-00007","volume":"139","author":"RS Vasan","year":"2004","unstructured":"Vasan RS, Sullivan LM, D\u2019Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, Wilson PW. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med. 2004;139:642\u20138.","journal-title":"Ann Intern Med"},{"key":"2030_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/oxfordjournals.eurheartj.a060047","volume":"13","author":"G Kahaly","year":"1992","unstructured":"Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J. Arrhythmia profile in acromegaly. Eur Heart J. 1992;13:51\u20136.","journal-title":"Eur Heart J"},{"key":"2030_CR16","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1210\/jc.2002-021099","volume":"88","author":"A Colao","year":"2003","unstructured":"Colao A, Spinelli L, Marzullo P, Pivonello R, Petretta M, Di Somma C, Vitale G, Bonaduce D, Lombardi G. High prevalence of cardiac valve disease in acromegaly: an observational analytical prospective case-control study. J Clin Endocrinol Metab. 2003;88:3196\u2013201.","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1210\/jc.2003-030849","volume":"89","author":"AM Pereira","year":"2004","unstructured":"Pereira AM, van Thiel SW, Lindner JR, Roelfsema F, van der Wall EE, Morreau H, Smit JW, Romijn JA, Bax JJ. Increased prevalence of regurgitant valvular heart disease in acromegaly. J Clin Endocrinol Metab. 2004;89:71\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2030_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/clc.22867","volume":"41","author":"AN Sharma","year":"2018","unstructured":"Sharma AN, Tan M, Amsterdam EA, Singh GD. Acromegalic cardiomyopathy: epidemiology, diagnosis, and management. Clin Cardiol. 2018;41(3):419\u201325.","journal-title":"Clin Cardiol"},{"key":"2030_CR19","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558\u201373.","journal-title":"N Engl J Med"},{"key":"2030_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/EJE-16-0117","volume":"175","author":"J Dal","year":"2016","unstructured":"Dal J, Feldt-Rasmussen U, Andersen M, et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol. 2016;175:181\u201390.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2030_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1536\/jhj.43.69","volume":"43","author":"A Shimakura","year":"2002","unstructured":"Shimakura A, Miyakoshi H, Ohkuwa H, Kitabayashi M, Komai T, Hisada A, Aoki K, Sakagami S, Kobayashi K, Takata S. Improvement of cardiac function after treatment with octreotide followed by trans-sphenoidal surgery in an acromegalic patient who presented with congestive heart failure. Jpn Heart J. 2002;43(1):69\u201377.","journal-title":"Jpn Heart J"},{"issue":"Suppl 1","key":"2030_CR22","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1530\/eje.0.151s093","volume":"151","author":"A Colao","year":"2004","unstructured":"Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C, Lombardi G. The heart: an end-organ of GH action. Eur J Endocrinol. 2004;151(Suppl 1):S93\u2013101.","journal-title":"Eur J Endocrinol"},{"key":"2030_CR23","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1210\/jc.2004-0821","volume":"89","author":"H Bihan","year":"2004","unstructured":"Bihan H, Espinosa C, Valdes-Socin H, et al. Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab. 2004;89:5308\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"2030_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/bmj.327.7406.78","volume":"327","author":"P MacCarthy","year":"2003","unstructured":"MacCarthy P, Kearney M, Nolan J, et al. Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study. BMJ. 2003;327:78\u20139.","journal-title":"BMJ"},{"key":"2030_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/s-0042-123710","volume":"125","author":"J Thomas","year":"2017","unstructured":"Thomas J, Dattani A, Zemrak F, et al. Renin-angiotensin system blockade improves cardiac indices in acromegaly patients. Exp Clin Endocrinol Diabetes. 2017;125:365\u20137.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2030_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/1074248406296676","volume":"11","author":"ER Schwarz","year":"2006","unstructured":"Schwarz ER, Jammula P, Gupta R, et al. A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both? J Cardiovasc Pharmacol Ther. 2006;11:232\u201344.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"11","key":"2030_CR27","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/eurheartj\/14.11.1572","volume":"14","author":"B Albat","year":"1993","unstructured":"Albat B, Leclercq F, Serre I, Fille A, Baldet P, Grolleau-Raoux R, Thevenet A. Heart transplantation for terminal congestive heart failure in an acromegalic patient. Eur Heart J. 1993;14(11):1572\u20135.","journal-title":"Eur Heart J"},{"key":"2030_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/europace\/euv352","volume":"18","author":"S Barra","year":"2016","unstructured":"Barra S, Looi KL, Gajendragadkar PR. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy. Europace. 2016;18:1187\u201393.","journal-title":"Europace."},{"issue":"5","key":"2030_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.hrthm.2014.02.014","volume":"11","author":"M Ogano","year":"2014","unstructured":"Ogano M, Iwasaki YK, Tanabe J, Takagi H, Umemoto T, Hayashi M, Miyauchi Y, Shimizu W. Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block. Heart Rhythm. 2014;11(5):836\u201341.","journal-title":"Heart Rhythm"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2030-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2030-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2030-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T23:22:27Z","timestamp":1587684147000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2030-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2030"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2030-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"4 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"106"}}